Germline-activating mutations in SHP2 cause Noonan syndrome, whereas somatic gain of function SHP2 mutations have been identified in several haematologic malignancies, most notably juvenile myelomonocytic leukaemia. The gene discussed is PTPN11; the disease is Noonan syndrome.